|
Symbol
|
RMAMHV | KYCWDU | OHTRCH | RMA2NV | OKYRCH | OOZRCH | AAGITQ | KYNGDU | CDKBKB | OSLRCH | KYUADU | OWRRCH | ABCVTQ | RMA6QV | KYZSDU | KYXXDU | ABICTQ | RMBQ5V | KZEHDU | ABKMTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Pfizer Inc. | Eli Lilly & Co. / Merck & Co. Inc. | Eli Lilly / Merck & Co. / Pfizer | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) | Abbott Laboratories / Eli Lilly & Co. / Merck & Co. Inc. | Eli Lilly & Co. / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly / Merck & Co. / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly / Merck & Co. / Pfizer | Eli Lilly & Co. / Merck & Co. Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche AG | Eli Lilly / Pfizer | Eli Lilly & Co. / Merck & Co. Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Johnson & Johnson / Merck & Co. Inc. / Pfizer Inc. |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
02.03.2026 | 05.06.2026 | 03.03.2026 | 23.06.2026 | 24.12.2025 | 22.01.2026 | 12.01.2026 | 09.02.2026 | 26.02.2026 | 19.08.2026 | 18.09.2026 | 20.03.2026 | 07.01.2026 | 27.03.2026 | 23.04.2026 | 09.04.2026 | 05.05.2026 | 17.11.2026 | 20.11.2026 | 12.11.2026 |
| Bid | 37.100 | - | 100.84 | 100.00 | - | 81.73 | 33.630 | - | 36.360 | 38.720 | - | - | 42.170 | 39.800 | - | 52.00 | 45.160 | - | 57.90 | - |
| Ask | - | - | 101.65 | 101.00 | - | - | - | - | - | - | - | - | - | - | - | 53.00 | - | - | 58.90 | - |